Informa Healthcare publishes two fully open access titles, Journal of Drug Assessment (JDA) and Journal of European CME (JECME). A subscription or hybrid model applies, however, for the remaining 166 journals in our portfolio.
If you are looking to extend the readership of an article or a special issue in a subscription title, we offer two options that give readers full online access to our content. We highlight the differences below, but please contact a member of our team if you require further detail.
Sponsored Access
Sponsored Access permits readers to access articles or book chapters for a fixed period of time, typically 3 or 6 months. Anyone can sponsor an article, chapter or content collection, and material can be sponsored at any point before or after publication. Articles and chapters can be grouped into a content collection, making Sponsored Access a cost-effective option if you are seeking to make more than one article or chapter available.
Open Access
Unlike Sponsored Access, Open Access is only available for journal articles and must be purchased by an author named on the manuscript at the point of publication. Open Access is an arrangement where the copyright for an article transfers from Informa Healthcare to the public domain. This means that readers can freely access the article on our site and on any site that includes the article content. The full text of the article is also archived on PubMed Central.
The advantage of Open Access is that the article remains accessible and can be openly shared. There is, however, a fixed per-article charge for this option — articles cannot be bundled.
